Raxibacumab, medically designated as PAmAb ABthrax, is a novel treatment approach against the infection. This single antibody , developed by the company , uniquely targets the protective antigen of https://raxibacumab-cell-experim157478.blogdigy.com/raxibacumab-a-in-depth-investigation-into-the-pa-ma-ab-infection-69678622